Jacobs Levy Equity Management’s AbbVie ABBV Stock Holding History

Jacobs Levy Equity Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-148,694	Closed	-$13M	–	1006
2020 Q3	$13M	Sell	148,694 -80,409	-35%	-$7.57M	0.14%	171
2020 Q2	$22.5M	Sell	229,103 -670,716	-75%	-$59.1M	0.24%	109
2020 Q1	$68.6M	Sell	899,819 -256,525	-22%	-$21.9M	0.88%	14
2019 Q4	$102M	Buy	1,156,344 +688,492	+147%	+$57.2M	1%	10
2019 Q3	$35.4M	Sell	467,852 -37,226	-7%	-$2.55M	0.43%	50
2019 Q2	$36.7M	Buy	505,078 +223,068	+79%	+$17.5M	0.51%	44
2019 Q1	$22.7M	Buy	+282,010	New	+$23.1M	0.33%	78
2016 Q1	–	Sell	-370,980	Closed	-$22M	–	1088
2015 Q4	$22M	Sell	370,980 -298,554	-45%	-$17.2M	0.44%	69
2015 Q3	$36.4M	Buy	669,534 +2,110	+0.3%	+$137K	0.75%	25
2015 Q2	$44.8M	Sell	667,424 -344,926	-34%	-$22.5M	0.85%	18
2015 Q1	$59.3M	Buy	1,012,350 +803,360	+384%	+$48.5M	1.01%	11
2014 Q4	$13.7M	Buy	+208,990	New	+$13.2M	0.23%	129
2014 Q3	–	Sell	-24,200	Closed	-$1.37M	–	814
2014 Q2	$1.37M	Sell	24,200 -80,950	-77%	-$4.25M	0.02%	459
2014 Q1	$5.41M	Buy	105,150 +92,250	+715%	+$4.66M	0.09%	248
2013 Q4	$681K	Sell	12,900 -618,144	-98%	-$30.4M	0.01%	658
2013 Q3	$28.2M	Buy	631,044 +626,044	+12,521%	+$27.8M	0.48%	56
2013 Q2	$207K	Buy	+5,000	New	+$219K	﹤0.01%	885

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jacobs Levy Equity Management's ABBV Position: Q4 2020 in Review

Jacobs Levy Equity Management sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 148,694 shares — an estimated $13M sold.

Jacobs Levy Equity Management first reported a position in ABBV in Q2 2013 and held it in 17 quarters. The position peaked at $102M in Q4 2019. 2,599 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

Jacobs Levy Equity Management reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
Jacobs Levy Equity Management sold 148,694 AbbVie shares in Q4 2020, an estimated $13M.
Jacobs Levy Equity Management first reported a position in AbbVie in Q2 2013 and held it in 17 quarters.
Jacobs Levy Equity Management's AbbVie position peaked at $102M in Q4 2019.
2,599 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.